期刊
FEBS JOURNAL
卷 283, 期 18, 页码 3303-3324出版社
WILEY
DOI: 10.1111/febs.13704
关键词
induced pluripotent stem cells; kidney disease; kidney engineering; pluripotent stem cells; renal differentiation
资金
- Fundacio Privada La Marato de TV3 [121430/31/32]
- Spanish Ministry of Economy and Competitiveness [SAF2014-59778]
- Commission for Universities and Research of the Department of Innovation, Universities and Enterprise of the Generalitat de Catalunya [2014 SGR 1442]
- La Fundacio Privada La Marato de TV3 [121430/31/32]
- Glenn Foundation
- G. Harold and Leila Y. Mathers Charitable Foundation
- Leona M. and Harry B. Helmsley Charitable Trust
- [StG-2014-640525_REGMAMKID]
- [RyC 2014-16242]
The kidney is the most important organ for water homeostasis and waste excretion. It performs several important physiological functions for homeostasis: it filters the metabolic waste out of circulation, regulates body fluid balances, and acts as an immune regulator and modulator of cardiovascular physiology. The development of in vitro renal disease models with pluripotent stem cells (both human embryonic stem cells and induced pluripotent stem cells) and the generation of robust protocols for in vitro derivation of renal-specific-like cells from patient induced pluripotent stem cells have just emerged. Here we review major findings in the field of kidney regeneration with a major focus on the development of stepwise protocols for kidney cell production from human pluripotent stem cells and the latest advances in kidney bioengineering (i.e. decellularized kidney scaffolds and bioprinting). The possibility of generating renal-like three-dimensional structures to be recellularized with renal-derived induced pluripotent stem cells may offer new avenues to develop functional kidney grafts on-demand.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据